PE20061197A1 - Aminoalcoholes triciclicos, como inhibidores de la secresion de citoquina il-8 - Google Patents

Aminoalcoholes triciclicos, como inhibidores de la secresion de citoquina il-8

Info

Publication number
PE20061197A1
PE20061197A1 PE2006000009A PE2006000009A PE20061197A1 PE 20061197 A1 PE20061197 A1 PE 20061197A1 PE 2006000009 A PE2006000009 A PE 2006000009A PE 2006000009 A PE2006000009 A PE 2006000009A PE 20061197 A1 PE20061197 A1 PE 20061197A1
Authority
PE
Peru
Prior art keywords
alkyl
inhibitors
hexahidrobenzo
trifluoromethyl
cycloalkyl
Prior art date
Application number
PE2006000009A
Other languages
English (en)
Inventor
Markus Berger
Norbert Schmees
Stefan Baurle
Anne Mengel
Danja Grossbach
David Voigtlander
Konrand Krolikiewicz
Hartmut Rehwinkel
Heike Schacke
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PE20061197A1 publication Critical patent/PE20061197A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 Y R2 SON CADA UNO H, HIDROXI, HALOGENO, ALQUILO C1-C10, ENTRE OTROS; R3 ES H, HIDROXI, HALOGENO, ALQUILTIO C1-C10, ENTRE OTROS; R4 ES ALQUILO C1-C10 SUSTITUIDO O NO, CICLOALQUILO C3-C7, HETEROCICLILO SUSTUITUIDO O NO, ENTRE OTROS; R5 ES ALQUILO C1-C5, CICLOALQUILO C3-C7, (CICLOALQUILO C3-C7)-(ALQUENILO C2-C8), HETEROCICLILO, ENTRE OTROS; R6 Y R7 SON CADA UNO H, HALOGENO, ALQUILO C1-C5 SUSTITUIDO O NO, ENTRE OTROS; p ES 1-3; X ES O, S, CH2, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 6-[(7-FLUORO-2-METILQUINAZOLIN-5-IL)AMINO]-5-(TRIFLUOROMETIL)-2,3,3a,4,5,6-HEXAHIDROBENZO[DE]CROMEN-5-OL; 9-FLUORO-6-[(2-METILQUINOLIN-5-IL)AMINO]-5-(TRIFLUOROMETIL)-2,3,3a,4,5,6-HEXAHIDROBENZO[DE]CROMEN-5-OL; 5-{[5-HIDROXI-5-(TRIFLUOROMETIL)-2,3,3a,4,5,6-HEXAHIDROBENZO[DE]CROMEN-6-IL]AMINO}-2-METILFTALAZIN-1-ONA; ENTRE OTROS. REFERIDA TAMBIEN A UN COMPOSCION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA SECRESION DE LA CITOQUINA IL-8 PROVOCADA POR LIPOPOLISACARIDOS (LPS) UTILES EN EL TRATAMIENTO DE LA INFLAMACION
PE2006000009A 2004-12-22 2006-01-03 Aminoalcoholes triciclicos, como inhibidores de la secresion de citoquina il-8 PE20061197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063227A DE102004063227A1 (de) 2004-12-22 2004-12-22 Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Publications (1)

Publication Number Publication Date
PE20061197A1 true PE20061197A1 (es) 2006-12-07

Family

ID=36250953

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000009A PE20061197A1 (es) 2004-12-22 2006-01-03 Aminoalcoholes triciclicos, como inhibidores de la secresion de citoquina il-8

Country Status (14)

Country Link
JP (1) JP2008524300A (es)
KR (1) KR20070089948A (es)
CN (1) CN101087780A (es)
AR (1) AR055016A1 (es)
AU (1) AU2005318354A1 (es)
BR (1) BRPI0519710A2 (es)
CA (1) CA2586973A1 (es)
DE (1) DE102004063227A1 (es)
GT (1) GT200500385A (es)
IL (1) IL183060A0 (es)
MX (1) MX2007007420A (es)
PA (1) PA8657801A1 (es)
PE (1) PE20061197A1 (es)
WO (1) WO2006066950A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1670458T3 (pl) 2003-10-08 2007-05-31 Bayer Schering Pharma Ag 1-amino-2-hydroksy-podstawione pochodne tetrahydronaftalenu, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenie
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7402596B2 (en) 2005-03-24 2008-07-22 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
EP1834948A1 (de) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途
EP1917963A1 (en) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
EP2072509A1 (en) 2007-12-18 2009-06-24 Bayer Schering Pharma Aktiengesellschaft 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents
EP2812324B1 (en) 2012-02-08 2021-09-01 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
EP3490607A4 (en) 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
CN116514761A (zh) 2016-07-29 2023-08-01 赛诺维信制药公司 化合物、组合物及其用途
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
KR20210139376A (ko) 2019-03-14 2021-11-22 선오비온 파마슈티컬스 인코포레이티드 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물
KR102462991B1 (ko) * 2020-11-02 2022-11-04 한국해양과학기술원 남극-유래 진균 균주 아크레모늄(Acremonium sp.) SF-7394에서 분리한 화합물 및 이를 포함하는 항염증, 항암 또는 항당뇨용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038639A1 (de) * 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
ES2298508T3 (es) * 2002-03-26 2008-05-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
DE10215316C1 (de) * 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
PL1670458T3 (pl) * 2003-10-08 2007-05-31 Bayer Schering Pharma Ag 1-amino-2-hydroksy-podstawione pochodne tetrahydronaftalenu, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenie
GB0418045D0 (en) * 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
DE102004044680B3 (de) * 2004-09-09 2006-06-08 Schering Ag Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
AU2005318354A1 (en) 2006-06-29
KR20070089948A (ko) 2007-09-04
DE102004063227A1 (de) 2006-07-06
JP2008524300A (ja) 2008-07-10
MX2007007420A (es) 2007-07-17
CA2586973A1 (en) 2006-06-29
IL183060A0 (en) 2007-09-20
CN101087780A (zh) 2007-12-12
GT200500385A (es) 2006-08-03
WO2006066950A3 (de) 2006-08-17
WO2006066950A2 (de) 2006-06-29
PA8657801A1 (es) 2006-12-07
AR055016A1 (es) 2007-08-01
BRPI0519710A2 (pt) 2009-03-10

Similar Documents

Publication Publication Date Title
PE20061197A1 (es) Aminoalcoholes triciclicos, como inhibidores de la secresion de citoquina il-8
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
PE20080772A1 (es) Nuevos derivados de bipiridina sustituidos y su uso
TW200740773A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
AR061644A1 (es) Derivados de benzofurano
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
PE20060487A1 (es) Derivados de 2-carbamida-4-feniltiazol como moduladores de la actividad de quimioquinas
PE20060383A1 (es) Nuevos derivados amino de urea ciclicos como inhibidores de quinasa
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
PE20130242A1 (es) Derivados de isoxazolo-piridina
PE20050907A1 (es) Pirimidinas sustituidas con sulfoximina como inhibidores de quinasa dependiente de ciclinas
EA200900177A1 (ru) Замещенные ациланилиды и способы их применения
PE20110409A1 (es) Compuestos heterociclicos antiviricos
PE20080768A1 (es) Compuestos de isoindolina 5-sustituidos
PE20060736A1 (es) DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2
PE20061377A1 (es) Compuestos heterociclicos fusionados
PE20080677A1 (es) Inhibidores de pirrolotriazina cinaza
CO6300954A2 (es) Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk
PE20080842A1 (es) Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
PE20141228A1 (es) Derivados de pirrolopirimidina y purina
PE20080150A1 (es) Derivados de piridinona n-aril y n-heteroaril sustituidos como antagonistas del receptor de la hormona concentradora de melanina (mch)
PE20080275A1 (es) Derivados de 5h-benzo[4,5]ciclohepta[1,2]piridina como inhibidores de tirosina quinasa
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
TW200745056A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
PE20070016A1 (es) Compuestos heterociclicos n-enlazados como antagonistas del receptor p2y1

Legal Events

Date Code Title Description
FC Refusal